RYSTIGGO
RYSTIGGO
Approved
DIN Number
02556081
Drug Class
Human
Market Date
N/A
Company
HC
UCB Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02556081
AIG Number0166605001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AG16 ROZANOLIXIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:08.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
ROZANOLIXIZUMABActive
Strength: 140 MG / ML
Monograph: ROZANOLIXIZUMAB